Detection of chromosomal abnormalities associated with chronic lymphocytic leukemia: what is the best method?

Cancer Genetics and Cytogenetics

Volumn 195, Issue 1, 2009, Pages 37-42

  el Taweel, Maha ^a   Barin, Carole ^b   Cymbalista, Florence ^a,c   Eclache, Virginie ^a  

^a AVICENNE HOSPITAL   (France)

^b CHU BRETONNEAU   (France)

^c UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; MITOGENIC AGENT;

ADULT; AGED; ARTICLE; CELL CULTURE; CHROMOSOME 11Q; CHROMOSOME ABERRATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE LOCUS; GENE LOSS; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MALE; MOLECULAR PROBE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; TRISOMY 12;

ADULT; AGED; AGED, 80 AND OVER; CELLS, CULTURED; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED;

EID: 70349876859     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.06.004     Document Type: Article

References (21)

1. Rai K.R., Sawitsky A., Cronkite E.P., Chanana A.D., Levy R.N., and Pasternack B.S. Clinical staging of chronic lymphocytic leukemia. Blood 46 (1975) 219-234
2. Binet J.L., Auquier A., Dighiero G., Chastang C., Piguet H., Goasguen J., Vaugier G., Potron G., Colona P., Oberling F., Thomas M., Tchernia G., Jacquillat C., Boivin P., Lesty C., Duault M.T., Monconduit M., Belabbes S., and Gremy F. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survey analysis. Cancer 48 (1981) 198-206
3. Binet J.L., Caligaris-Cappio F., Catovsky D., Cheson B., Davis T., Dighiero G., Döhner H., Hallek M., Hillmen P., Keating M., Montserrat E., Kipps T.J., and Rai K. International Workshop on Chronic Lymphocytic Leukemia (IWCLL). Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia. Blood 107 (2006) 859-861
4. Crespo M., Bosch F., Villamor N., Bellosillo B., Colomer D., Rozman M., Marcé S., López-Guillermo A., Campo E., and Montserrat E. ZAP-70 expression as a surrogate for immunoglobulin variable-region mutations in chronic lymphocytic leukemia. N Engl J Med 348 (2003) 1764-1775
5. Juliusson G., Oscier D.G., Fitchett M., Ross F.M., Stockdill G., Mackie M.J., Parker A.C., Castoldi G.L., Guneo A., and Knuutila S. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med 323 (1990) 720-724
6. Döhner H., Stilgenbauer S., Benner A., Leupolt E., Kröber A., Bullinger L., Döhner K., Bentz M., and Lichter P. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343 (2000) 1910-1916
7. Mayr C., Speicher M.R., Kofler D.M., Buhmann R., Strehl J., Busch R., Hallek M., and Wendtner C.M. Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia. Blood 107 (2006) 742-751
8. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., Aldler H., Rattan S., Keating M., Rai K., Rassenti L., Kipps T., Negrini M., Bullrich F., and Croce C.M. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99 (2002) 15524-15529
9. Cimmino A., Calin G.A., Fabbri M., Iorio M.V., Ferracin M., Shimizu M., Wojcik S.E., Aqeilan R.I., Zupo S., Dono M., Rassenti L., Alder H., Volinia S., Liu C.G., Kipps T.J., Negrini M., and Croce C.M. miR-15 and miR-16 induce apoptosis targeting BCL2. [Erratum in: Proc Natl Acad Sci USA 2006;103:2464]. Proc Natl Acad Sci USA 102 (2005) 13944-13949
10. H gene mutation status in pathogenesis and clinical course. Leukemia 16 (2002) 993-1007
11. Mittal A.K., Hegde G.V., Aoun P., Bociek R.G., Dave B.J., Joshi A.D., Sanger W.G., Weisenburger D.D., and Joshi S.S. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities. Int J Mol Med 20 (2007) 461-469
12. Matutes E., Owusu-Ankomah M.R., Garcia Marco J., Houlihan A., Que T.H., and Catovsky D. The immunological profile of disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 8 (1994) 1640-1645
13. In: Shaffer L.G., and Tommerup N. (Eds). ISCN 2005: an international system for human cytogenetic nomenclature (2005) (2005), S. Karger, Basel
14. H status, and CD38 expression. Blood 108 (2006) 3152-3160
15. H status and immunophenotyping. Leukemia 21 (2007) 2442-2451
16. Van Den Neste E., Robin V., Francart J., Hagemeijer A., Stul M., Vandenberghe P., Delannoy A., Sonet A., Deneys V., Costantini S., Ferrant A., Robert A., and Michaux L. Chromosomal translocations independently predict failure, treatment-free survival and overall survival in B-cell chronic lymphocytic leukemia patients treated with cladribine. Leukemia 21 (2007) 1715-1722
17. Stockero K.J., Fink S.R., Smoley S.A., Paternoster S.F., Shanafelt T.D., Call T.G., Zent C.S., Van Dyke D.L., Kay N.E., and Dewald G.W. Metaphase cells with normal G-bands have cryptic interstitial deletions in 13q14 detectable by fluorescent in situ hybridization in B-cell chronic lymphocytic leukemia. Cancer Genet Cytogenet 166 (2006) 152-156
18. Dicker F., Herholz H., Schnittger S., Nakao A., Patten N., Wu L., Kern W., Haferlach T., and Haferlach C. The detection of TP53 mutations in chronic lymphocytic leukemia independently predicts rapid disease progression and is highly correlated with a complex aberrant karyotype. Leukemia 23 (2009) 117-124
19. Oscier D.G., Gardiner A.C., Mould S.J., Glide S., Davis Z.A., Ibbotson R.E., Corcoran M.M., Chapman R.M., Thomas P.W., Copplestone J.A., Orchard J.A., and Hamblin T.J. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood 100 (2002) 1177-1184
20. Sánchez J., and Aventín A. Detection of chromosomal abnormalities in chronic lymphocytic leukemia increased by interphase fluorescence in situ hybridization in tetradecanoylphorbol acetate-stimulated peripheral blood cells. Cancer Genet Cytogenet 175 (2007) 57-60
21. Fink S.R., Smoley S.A., Stockerp K.J., Paternoster S.F., Thorland E.C., Van Dyke D.L., Shanafelt T.D., Zent C.S., Call T.G., Kay N.E., and Dewald G.W. Loss of TP53 is due to rearrangements involving chromosome region 17p10∼p12 in chronic lymphocytic leukemia. Cancer Genet Cytogenet 167 (2006) 177-181